OptraScan
OptraSCAN is a pioneering digital pathology company that offers advanced digital slide scanners and AI-driven solutions to transform pathology services. Their business model includes an On-Demand Digital Pathology® approach, allowing users to pay only for what they use, making digital pathology accessible and affordable. Key products include a range of whole slide scanners, AI-based analytics for automated tissue abnormality detection, telepathology for remote consultations, e-learning platforms, and secure image management software. OptraSCAN's technology enhances diagnostic accuracy, workflow efficiency, and collaboration in pathology labs, supporting research, education, and clinical practice. The company holds various patents on automatic scanning devices and intelligent scoring systems and is certified with ISO 13485, CE-IVDR, and CDSCO. Their solutions are scalable and integrate seamlessly with existing lab systems, serving healthcare institutions globally to improve patient outcomes and streamline pathology workflows.
OptraScan
OptraSCAN is a pioneering digital pathology company that offers advanced digital slide scanners and AI-driven solutions to transform pathology services. Their business model includes an On-Demand Digital Pathology® approach, allowing users to pay only for what they use, making digital pathology accessible and affordable. Key products include a range of whole slide scanners, AI-based analytics for automated tissue abnormality detection, telepathology for remote consultations, e-learning platforms, and secure image management software. OptraSCAN's technology enhances diagnostic accuracy, workflow efficiency, and collaboration in pathology labs, supporting research, education, and clinical practice. The company holds various patents on automatic scanning devices and intelligent scoring systems and is certified with ISO 13485, CE-IVDR, and CDSCO. Their solutions are scalable and integrate seamlessly with existing lab systems, serving healthcare institutions globally to improve patient outcomes and streamline pathology workflows.
TL;DR
What they do: Digital pathology company selling whole-slide scanners, AI analytics, and cloud image management
Business model: On-Demand / pay-per-use digital pathology and subscription offerings
Regulatory / quality: ISO 13485 certified; CE-IVDR and CDSCO approvals reported
Recent funding: Series B announced Nov 6, 2024; lead investor Molbio Diagnostics
Headcount: ~50 employees reported